However, unlike the sustained period of GPR40 knockout mice, in this experiment, although the serum insulin levels were reduced, treatment of DC260126 might start too late or last too short to fail to reverse the process of hyperlipidemia and hyperglycemia in db/db mice. This evidence concerns the gene INS and Hyperglycemia.